Skip to main content

Table 2 Baseline characteristics of the patients

From: Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial

  ESWT (n = 11) PLACEBO (n = 9) P value
*Age (years) 50.7 ± 8.44 (38-64) 51.11 ± 13.26 (36-74) 0.938§
Sex    
  Men 7 4 0.653
  Women 4 5  
*BMI 27.4 ± 1.04 (26-29.4) 24.4 ± 3.15 (19-29) 0.024§
*Duration of symptoms (months) 45.36 ± 34.33 (11-131) 61.22 ± 24.04 (34-97) 0.258§
Affected side    
  Right 7 6 0.999
  Left 4 3  
Patients with physiotherapy 7 8 0.319
Acromion slope    
  Type I 8 7 0.999
  Type II 2 2  
  Type III 1 0  
  1. *The values are given as mean ± standard deviation (range).
  2. ESWT, extracorporeal shock wave therapy; BMI, body mass index; ST, supraspinatus tendon.
  3. § Unpaired t-test.
  4. Monte Carlo or Fisher exact test.
  5. Mann-Whitney U-test.